BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31108340)

  • 1. Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors.
    Jamy O; Sarmad R; Costa L
    Leuk Res; 2019 Jul; 82():1-6. PubMed ID: 31108340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
    Rebora P; Czene K; Antolini L; Gambacorti Passerini C; Reilly M; Valsecchi MG
    Am J Epidemiol; 2010 Nov; 172(9):1028-33. PubMed ID: 20861143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
    Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
    Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
    Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM
    Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.
    Nakazato T; Iriyama N; Tokuhira M; Ishikawa M; Sato E; Takaku T; Sugimoto KJ; Fujita H; Fujioka I; Kimura Y; Aisa Y; Iwanaga E; Asou N; Kizaki M; Hatta Y; Komatsu N; Kawaguchi T
    Med Oncol; 2018 May; 35(7):99. PubMed ID: 29846829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.
    Brunner AM; Campigotto F; Sadrzadeh H; Drapkin BJ; Chen YB; Neuberg DS; Fathi AT
    Cancer; 2013 Jul; 119(14):2620-9. PubMed ID: 23625575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
    Sasaki K; Kantarjian HM; O'Brien S; Ravandi F; Konopleva M; Borthakur G; Garcia-Manero G; Wierda WG; Daver N; Ferrajoli A; Takahashi K; Jain P; Rios MB; Pierce SA; Jabbour EJ; Cortes JE
    Int J Hematol; 2019 May; 109(5):545-552. PubMed ID: 30830579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship.
    Koller PB; Kantarjian HM; Nogueras-Gonzalez GM; Jabbour E; Verstovsek S; Borthakur G; Estrov Z; Wierda WG; Garcia-Manero G; Ferrajoli A; Ravandi F; O'Brien SM; Cortes JE
    Cancer; 2017 Feb; 123(4):609-616. PubMed ID: 27763690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors.
    Yin XF; Wang JH; Li X; Yu MX; Ma ZX; Jin J
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):577-581. PubMed ID: 27397576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.
    Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Polychronopoulou S; Stiakaki E; Moschovi M; Hatzipantelis E; Kourti M; Graphakos S; Pombo-de-Oliveira MS; Adami HO; Petridou ET
    Eur J Cancer; 2016 Nov; 67():183-190. PubMed ID: 27677054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
    Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
    JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
    Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
    Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
    Gunnarsson N; Stenke L; Höglund M; Sandin F; Björkholm M; Dreimane A; Lambe M; Markevärn B; Olsson-Strömberg U; Richter J; Wadenvik H; Wallvik J; Själander A
    Br J Haematol; 2015 Jun; 169(5):683-8. PubMed ID: 25817799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
    Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
    Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
    J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
    Pulte D; Redaniel MT; Bird J; Jeffreys M
    Eur J Haematol; 2015 Jun; 94(6):540-5. PubMed ID: 25315799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
    Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
    Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.